Drug Treatment for Type 2 Diabetes
Findings of a network meta-analysis of drug treatments for type 2 diabetes “highlight the need for continuous assessment of scientific progress to introduce cutting edge
Michael Posey
April 10, 2023
Findings of a network meta-analysis of drug treatments for type 2 diabetes “highlight the need for continuous assessment of scientific progress to introduce cutting edge
Among women of child-bearing potential, a study shows less prenatal exposure to phentermine-topiramate — a product that requires a Risk Evaluation and Mitigation Strategy (REMS)
Four proven clinical interventions “should constitute a set of ‘universal precautions’ that clinicians and health systems could implement to reduce opioid overdose deaths among at-risk
The annual rate of hospitalizations and proportion per year of acute liver failure (ALF) cases involving acetaminophen (paracetamol) and opioids fell in the years after
As recommended in product labeling, liver enzyme monitoring is needed during the first 18 months of tolvaptan therapy and every 3 months thereafter, according to
In hospitalized patients transitioning to and in postacute care (PAC) facilities, a deprescribing intervention reduced the total medication burden. The effects were sustained at a
A 12-gene pharmacogenetic panel significantly reduced the incidence of clinically relevant adverse drug reactions when implemented across diverse European healthcare systems, researchers report. “Large-scale implementation”
Asking older adults about cannabis use and educating them about its effects should be a routine aspect of medical care, according to authors who studied
Buprenorphine-based treatment for opioid use disorder during the COVID-19 pandemic was not associated with an increased proportion of overdose deaths involving buprenorphine, according to results
The use of hydroxychloroquine is associated with an increased risk of retinopathy in a large cohort study, researchers report, and the risk of retinopathy increases